FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Fentanyl 100 microgram buccal tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Fentanyl 100 microgram buccal tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely lanthanum carbonate 250 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely lanthanum carbonate 250 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely aspirin 975 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely aspirin 975 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Paliperidone 3 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Paliperidone 3 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely dirithromycin 250 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely dirithromycin 250 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Salicylic acid 110 mg/g cutaneous gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Salicylic acid 110 mg/g cutaneous gel Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Benzoyl peroxide 100 mg/mL cutaneous cream Count of base of active ingredient False 1 Inferred relationship Some
    Benzoyl peroxide 100 mg/mL cutaneous cream Has concentration strength denominator value False 1 Inferred relationship Some 1
    Lidocaine hydrochloride 20 mg/g cutaneous gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Lidocaine hydrochloride 20 mg/g cutaneous gel Count of base of active ingredient False 1 Inferred relationship Some
    Levetiracetam 100 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Levetiracetam 100 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Glyceryl trinitrate 400 microgram sublingual tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Glyceryl trinitrate 400 microgram sublingual tablet Count of base of active ingredient False 1 Inferred relationship Some
    Lithium succinate 80 mg/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Lithium succinate 80 mg/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely verapamil hydrochloride 8 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely verapamil hydrochloride 8 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Estradiol 600 microgram/g cutaneous gel Count of base of active ingredient False 1 Inferred relationship Some
    Estradiol 600 microgram/g cutaneous gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Potassium iodide 65 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Potassium iodide 65 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Fluorouracil 20 mg/mL cutaneous solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Fluorouracil 20 mg/mL cutaneous solution Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Morphine sulfate 4 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Morphine sulfate 4 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Neomycin 5 mg/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Neomycin 5 mg/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Desoximetasone 2.5 mg/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Desoximetasone 2.5 mg/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Adrenaline 5 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Adrenaline 5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Tretinoin 400 microgram/g cutaneous gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Tretinoin 400 microgram/g cutaneous gel Count of base of active ingredient False 1 Inferred relationship Some
    Hydrocortisone valerate 2 mg/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Hydrocortisone valerate 2 mg/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Triamcinolone acetonide 250 microgram/mL cutaneous cream Count of base of active ingredient False 1 Inferred relationship Some
    Triamcinolone acetonide 250 microgram/mL cutaneous cream Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely adapalene 1 microgram/1 milligram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely adapalene 1 microgram/1 milligram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely adapalene 1 microgram/1 milligram conventional release cutaneous gel (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Nystatin 100 unit/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Nystatin 100 unit/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Tetracaine hydrochloride 5 mg/mL cutaneous solution Count of base of active ingredient False 1 Inferred relationship Some
    Tetracaine hydrochloride 5 mg/mL cutaneous solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Oxybutynin hydrochloride 100 mg/g cutaneous gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Oxybutynin hydrochloride 100 mg/g cutaneous gel Count of base of active ingredient False 1 Inferred relationship Some
    Desoximetasone 500 microgram/g cutaneous gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Desoximetasone 500 microgram/g cutaneous gel Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely oxymetazoline hydrochloride 2.5 milligram/1 milliliter conventional release nasal spray (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely oxymetazoline hydrochloride 2.5 milligram/1 milliliter conventional release nasal spray (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Salicylic acid 60 mg/g cutaneous gel Count of base of active ingredient False 1 Inferred relationship Some
    Salicylic acid 60 mg/g cutaneous gel Has concentration strength denominator value False 1 Inferred relationship Some 1
    Fludroxycortide 500 microgram/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Fludroxycortide 500 microgram/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Bacitracin 500 unit/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Bacitracin 500 unit/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some

    Start Previous Page 175 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start